Guidant Rethinks Everolimus-Eluting Stent Platform Strategy, Timeframes

Guidant acknowledges that its initial drug-eluting stent may have to be a cobalt-chromium, durable-polymer stent if design changes to the bioabsorbable-polymer Champion require renewed preclinical or clinical testing